Suppr超能文献

慢性β-肾上腺素能拮抗剂治疗会影响人T淋巴细胞的“体外”反应性。

Chronic beta-adrenergic antagonist treatment affects human T lymphocyte responsiveness "in vitro".

作者信息

Malec P H, Zeman K, Markiewicz K, Tchórzewski H

机构信息

Department of Cardiology, School of Medicine, Lódz, Poland.

出版信息

Allergol Immunopathol (Madr). 1990 Mar-Apr;18(2):83-5.

PMID:1973587
Abstract

The aim of the present study was the evaluation of the effect of long-term propranolol treatment on some immune parameters in humans. The subjects were 12 duodenal ulcer patients, aged 19-23 years. They were given propranolol in a dose of 40 mg three times a day orally. Blood samples were drawn before and after one-month propranolol treatment. The drug did not significantly affect mitogen (PHA, Con A, PWM)- induced lymphoproliferative response, although a tendency of a slight inhibition of proliferation was observed. In all patients treated with propranolol absolute peripheral blood lymphocyte counts increased. Propranolol did not significantly influence one-way MLR, while it enhanced proliferation in the AMLR test in all patients. The drug increased spontaneous and PHA-induced IL-2R expression as well as IL-2 generation. The study showed that chronic beta-adrenoceptor blockade with propranolol may modify some immune functions in humans.

摘要

本研究的目的是评估长期使用普萘洛尔治疗对人体某些免疫参数的影响。研究对象为12名年龄在19至23岁之间的十二指肠溃疡患者。他们口服普萘洛尔,剂量为40毫克,每日三次。在普萘洛尔治疗一个月前后采集血样。该药物对丝裂原(PHA、Con A、PWM)诱导的淋巴细胞增殖反应没有显著影响,尽管观察到有轻微抑制增殖的趋势。在所有接受普萘洛尔治疗的患者中,外周血淋巴细胞绝对计数增加。普萘洛尔对单向混合淋巴细胞反应没有显著影响,但在所有患者的双向混合淋巴细胞反应试验中增强了增殖。该药物增加了自发的和PHA诱导的IL-2R表达以及IL-2的产生。研究表明,普萘洛尔长期阻断β-肾上腺素受体可能会改变人体的某些免疫功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验